Kamal Afrin, Shakya Sampurna, Lopez Rocio, Thota Prashanthi N
Department of Gastroenterology and Hepatology, Digestive Diseases and Surgical Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.
Department of Qualitative Health Sciences, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.
Gastroenterol Rep (Oxf). 2018 Aug;6(3):177-183. doi: 10.1093/gastro/goy018. Epub 2018 Jun 2.
High-resolution esophageal manometry (HREM) is the diagnostic test of choice for evaluation of non-obstructive dysphagia. Studies regarding the predictors of esophageal dysmotility are limited. Therefore, our aim was to study the prevalence of and factors associated with esophageal motility disorders in patients with non-obstructive dysphagia.
We performed a retrospective review of all patients with non-obstructive dysphagia who underwent HREM in a tertiary center between 1 January 2014 and 31 December 2015. After obtaining IRB approval (16-051), clinical records were scrutinized for demographic data, symptoms, medication use, upper endoscopic findings and esophageal pH findings. HREM plots were classified per Chicago Classification version 3.0. Primary outcome was prevalence of esophageal motility disorders; secondary outcomes assessed predictive factors.
In total, 155 patients with non-obstructive dysphagia (55 ± 16 years old, 72% female) were identified. HREM diagnosis was normal in 49% followed by ineffective esophageal motility in 20%, absent contractility in 7.1%, achalasia type II in 5.8%, outflow obstruction in 5.2%, jackhammer esophagus in 4.5%, distal esophageal spasm in 3.9%, fragment peristalsis in 1.9%, achalasia type I in 1.9%, and achalasia type III in 0.6%. Men were five times more likely to have achalasia than women [odds ratio (OR) 5.3, 95% confidence interval (CI): 2.0-14.2; = 0.001]. Patients with erosive esophagitis (OR 2.9, 95% CI: 1.1-7.7; = 0.027) or using calcium channel blockers (OR 3.0, 95% CI: 1.2-7.4; = 0.015) were three times more likely to have hypomotility disorders.
From this study, we concluded that HREM diagnosis per Chicago Classification version 3.0 was normal in 49% of patients with non-obstructive dysphagia. Male gender, erosive esophagitis and use of calcium channel blockers were predictive of esophageal motility disorders.
高分辨率食管测压(HREM)是评估非梗阻性吞咽困难的首选诊断方法。关于食管动力障碍预测因素的研究有限。因此,我们的目的是研究非梗阻性吞咽困难患者食管动力障碍的患病率及相关因素。
我们对2014年1月1日至2015年12月31日在一家三级中心接受HREM检查的所有非梗阻性吞咽困难患者进行了回顾性研究。获得机构审查委员会批准(16 - 051)后,仔细查阅临床记录以获取人口统计学数据、症状、用药情况、上消化道内镜检查结果和食管pH值检查结果。HREM图谱根据芝加哥分类第3.0版进行分类。主要结局是食管动力障碍的患病率;次要结局评估预测因素。
共确定了155例非梗阻性吞咽困难患者(年龄55±16岁,72%为女性)。HREM诊断正常的占49%,其次是无效食管动力占20%,无收缩占7.1%,Ⅱ型贲门失弛缓症占5.8%,流出道梗阻占5.2%,强力型食管占4.5%,食管远端痉挛占3.9%,破碎蠕动占1.9%,Ⅰ型贲门失弛缓症占1.9%,Ⅲ型贲门失弛缓症占0.6%。男性患贲门失弛缓症的可能性是女性的5倍[比值比(OR)5.3,95%置信区间(CI):2.0 - 14.2;P = 0.001]。患有糜烂性食管炎的患者(OR 2.9,95% CI:1.1 - 7.7;P = 0.027)或使用钙通道阻滞剂的患者(OR 3.0,95% CI:1.2 - 7.4;P = 0.015)发生动力障碍的可能性是其他患者的3倍。
通过这项研究,我们得出结论,根据芝加哥分类第3.0版,49%的非梗阻性吞咽困难患者HREM诊断正常。男性、糜烂性食管炎和使用钙通道阻滞剂是食管动力障碍的预测因素。